CJC-1295 (no DAC), Hexarelin 10mg (Blend)

Hexarelin,which is a potent stimulator of the growth hormone secretagogue receptor. When combined with CJC-1295, a growth hormone releasing hormone receptor agonist, the two GH stimulants boost both baseline and peak levels of GH in animal models.

Both peptides have positive effects on cardiac (heart) muscle. Hexarelin, in particular, has been heavily investigated for its ability to protect heart cells from damage during ischemic injury (e.g. heart attack). There is good reason to believe that a combination of both peptides could improve outcomes during acute coronary events, aid recovery following myocardial injury, and even prevent cardiac injury in the first p^[1]–[3].

Hexarelin and CJC-1295 both potentiate fat metabolism and have been linked to improved measures of insulin resistance. Reduction in adipose tissue mass is linked to decreased systemic inflammation and improvements in everything from type 2 diabetes to the risk of developing cancer^[4]. Both peptides are also being investigated for their ability to protect muscle from the effects of chemotherapy^{[5], [6]}.

The above literature was researched, edited and organized by Dr. E. Logan, M.D. Dr. E. Logan holds a doctorate degree from Case Western Reserve University School of Medicine and a B.S. in molecular biology.